Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Enteric Microbiome Markers in the Early Prediction of Liver Transplantation Adverse Outcomes.

NCT03666312 is registered in ClinicalTrials.gov with Nicasio Mancini as lead sponsor.

NCT NCT03666312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03666312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Enteric Microbiome Markers in the Early Prediction of Liver Transplantation Adverse Outcomes.
Lead sponsor
Nicasio Mancini
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2018
Completion date
August 30, 2021
Enrollment
275 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

orthotopic liver transplantation